WAMEX Private Equity, a Mexican private equity firm, has invested US$32 million in Productos Medix, a Mexican pharmaceuticals manufacturer. Productos Medix has a portfolio of over 50 pharmaceutical products, prescribed throughout Mexico, Colombia and Argentina, for patients with obesity-related problems. The investment was made via WAMEX’s Multinational Industrial Fund II (MIF II), a US$160 million Mexico-focused private equity fund.